Thyroid dysfunction in women with suspected fibromyalgia;Disfunción tiroidea en mujeres con sospecha de fibromialgia

Reumatologia Clinica

Volumn 2, Issue 2, 2006, Pages 70-77

  Rodriguez Espinosa J ^a   Diaz Lopez C ^a   Guinot, M ^a   Geli, C ^a   de Llobet, J M ^a   Rodriguez de la Serna A ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Fibromyalgia; Thyroid function; Thyrotropin

Indexed keywords

LEVOTHYROXINE; THYROTROPIN;

ADULT; AGED; ARTICLE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; EUTHYROIDISM; FEMALE; FIBROMYALGIA; HIGH RISK POPULATION; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; OUTPATIENT; PREVALENCE; SCREENING TEST; THYROID DISEASE; THYROID FUNCTION TEST; THYROTROPIN BLOOD LEVEL;

EID: 33646569423     PISSN: 1699258X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1699-258X(06)73025-X     Document Type: Article

References (36)

1. Collado A, Alijotas J, Benito P, Alegre C, Romera M, Sañudo I, et al. Documento de consenso sobre el diagnóstico y tratamiento de la fibromialgia en Cataluña. Med Clin (Barc). 2002;118:745-9.
2. Valls-Llobet C. Dolor crónico y fatiga crónica una asignatura pendiente. Med Clín (Barc). 2003;121:412-3.
3. Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA. 2004;292;2388-95.
4. Díez JJ. Hipotiroidismo en el paciente anciano: importancia clínica y dificultades en el diagnóstico y tratamiento. Med Clín (Barc). 1998;111:742-50.
5. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol. 1977;7:481-93.
6. 4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination survey (NHANES III). J Clin Endocrinol Metab. 2002;87:489-99.
7. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160:526-34.
8. Attia J, Margetts P, Guyatt G. Diagnosis of thyroid disease in hospitalized patients. Arch Intern Med. 1999;159:658-65.
9. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004;291:228-38.
10. Helfand M; U.S. Preventive Services Task Force. Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2004;140: 128-41.
11. Shiroky JB, Cohen M, Ballachey ML, Neville C. Thyroid dysfunction in rheumatoid arthritis: a controlled prospective survey. Ann Rheum Dis. 1993;52:454-6.
12. Ramos-Casals M, García-Carrasco M, Cervera R, Gaya J, Halperin I, Ubieto I, et al. Thyroid disease in primary Sjögren syndrome. Study in a series of 160 patients. Medicine (Baltimore). 2000;79:103-8.
13. Pyne D, Isenherg DA. Autoimmune thyroid disease in systemic lupus erythematosus. Ann Rheum Dis. 2002;61:70-2.
14. Punzi L, Betterle C. Chronic autoimmune thyroiditis and rheumatic manifestations. Joint Bone Spine. 2004;71:275-83.
15. Shalev E, Eliyahu S, Ziv M, Ben-Ami M. Routine thyroid function tests in infertile women: are they necessary? Am J Obstet Gynecol. 1994;171: 1191-2.
16. Arojoki M, Jokimaa V, Juuti A, Koskinen P, Irjala K, Anttila L. Hypothyroidism among infertile women in Finland. Gynecol Endocrinol. 2000;14:127-31.
17. Consensus Document on Fibromyalgia: The Copenhagen Declaration. Journal of Musculoskeletal Pain, Vol. 1. New York The Haworth Press, Inc.; 1993.
18. Gascó Eguiluz E, Serna Arnaiz MC, Vázquez Torguet A, Peremiquel Lluch M, Ibarz Excuer M, Serra Majem L. Prevalencia de trastorno de la función tiroidea en la provincia de Lleida. Aten Primaria. 1999;24:475-9.
19. Gómez JM, Virgili N, Navarro MA, Roca M, Montaña E, Soler J. Estudio de los parámetros de función tiroidea y de la tirotropina en la enfermedad general no tiroidea. Med Clín (Barc). 1989;92:5-9.
20. Eggertsen R, Petersen K, Lundberg P-A, Nyström E, Lindstedt G. Screening for thyroid disease in primary care unit with a thyroid stimulating hormone assay with a low detection limit. Br Med J. 1988;297:1586-92.
21. Stockigt JR. Guidelines for diagnosis and monitoring of thyroid disease: nonthyroidal illness. Clin Chem. 1996;42:188-92.
22. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol. 1995;43:55-68.
23. National Academy of Clinical Biochemistry Web site. NACB laboratory medicine practice guidelines [consultado 17/01/2005]. Disponible en: http://www.nacb.org/lmpg/thyroid_LMPG_Word.stm
24. Deprés N, Grant AM. Antibody interference in thyroid assays: a potential for clinical misinformation. Clin Chem. 1998;44:440-54.
25. O'Reilly DSJ. Thyroid function tests time for a reassessment. BMJ. 2000; 320:1332-4.
26. Bastenie PA, Bonnyns M, Neve P, Vanhaelst L, Chailly M. Clinical and pathological significance of asymptomatic atrophic thyroiditis: a condition of latent hypothyroidism. Lancet. 1967;1:915-8.
27. Cooper DS. Thyroid disease in the oldest old. The exception to the rule. JAMA. 2004;292:2651-4.
28. Lucas Martín A. Hipotiroidismo subclínico: tratar o no tratar. Med Clin (Barc). 2004;122:182-3.
29. Cooper DS. Subclinical hypothyroridism. N Engl J Med. 2001;345:260-5.
30. Gussekloo J, Van Exel E, De Craen AJ, Meinders AE, Frolich M, Westendorp RG. Thyroid status, disability and cognitive function, and survival in old age. JAMA. 2004;292:2591-9.
31. Rodríguez Espinosa J. El laboratorio clínico: uso y abuso, modelos de gestión y gasto sanitario. Med Clin (Barc). 2005; 125:622-5.
32. Van Walraven C, Naylor CD. Do we know what inappropriate laboratory utilization is? A systematic review of laboratory clinical audits. JAMA. 1998;280:550-8.
33. Larsen PR, Ingbar SH. The thyroid gland. En: Wilson JD, Foster DW, editors. Williams Textbook of Endocrinology. 8th ed. Philadelphia: WB Saunders Co.; 1992. p. 448.
34. Beyer IW, Karmali R, Demeester-Mirkine N, Cogan E, Fuss MJ. Serum creatine kinase levels in overt and subclinical hypothyroidism. Thyroid. 1998;8:1029-31.
35. Wan Nazaimoon WM, Siaw FS, Sheriff IH, Faridah I, Hhalid BAK. Serum creatine kinase: an adjunt biochemical index of subclinical thyrotoxicosis. Ann Biochem. 2001;38:57-8.
36. a ed. Madrid: Editorial Paz Montalvo; 1977. p. 213.